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Abstract
Background: Though new technologies like Magnetic Resonance Imaging (MRI) may be accurate, they often diffuse into
practice before thorough assessment of their value in diagnosis and management, and of their effects on patient outcome
and costs. MRI of the knee is a common investigation despite concern that it is not always appropriate. There is wide
variation in general practitioners (GPs) access to, and use of MRI, and in the associated costs. The objective of this study
was to resolve uncertainty whether GPs should refer patients with suspected internal derangement of the knee for MRI
or to an orthopaedic specialist in secondary care.
Methods/Design: The design consisted of a pragmatic multi-centre randomised trial with two parallel groups and
concomitant economic evaluation. Patients presenting in general practice with suspected internal derangement of the
knee and for whom their GP was considering referral to an orthopaedic specialist in secondary care were eligible for
inclusion. Within practices, GPs or practice nurses randomised eligible and consenting participants to the local radiology
department for an MRI examination, or for consultation with an orthopaedic specialist. To ensure that the waiting time
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from GP consultation to orthopaedic appointment was similar for both trial arms, GPs made a provisional referral to
orthopaedics when requesting the MRI examination. Thus we evaluated the more appropriate sequence of events
independent of variations in waiting times. Follow up of participants was by postal questionnaires at six, twelve and 24
months after randomisation. This was to ensure that the evaluation covered all events up to and including arthroscopy.
Discussion: The DAMASK trial should make a major contribution to the development of evidence-based partnerships
between primary and secondary care professionals and inform the debate when MRI should enter the diagnostic pathway.
Background
Each year in the United Kingdom (UK) 15% of patients
who consult general practitioners (GPs) do so for muscu-
loskeletal disorders. The annual consulting rate for inter-
nal derangement of the knee is 32 per 1000 patient years,
similar to rheumatoid arthritis [1]. Imaging of the knee is
a common musculoskeletal application of Magnetic Reso-
nance Imaging (MRI) [2]. Although there is evidence for
the technical [3] and diagnostic [4-6] performance of MRI
for knee problems, there is uncertainty about the appro-
priate use of MRI, in particular when it should enter the
diagnostic pathway for patients with suspected internal
derangement of the knee [7,8]. This question is crucial to
patient diagnosis, management and outcome, and thus to
cost-effectiveness.
Systematic reviews have consistently demonstrated that
MRI is an accurate diagnostic test for detecting meniscal
and cruciate lesions [7-12]. For example, at least 85% of
meniscal lesions and 90% of healthy menisci found at
arthroscopy are detected with MRI [10]. A trial that
included 209 patients with negative MRI results who were
randomised for arthroscopic or conservative treatment
also concluded that MRI is accurate for the diagnosis of
knee injuries [13]. Therefore the evidence supports the use
of MRI for diagnosing these common problems. This has
led some to suggest that it is valuable to GPs in making
appropriate and informed decisions [14,15]. Negative
MRI findings could allow GPs to reassure patients, treat
them conservatively in primary care, avoid unnecessary
orthopaedic referrals and hence reduce waiting times [2,3]
and save costs [16]. Alternatively positive MRI findings
could confirm GPs' clinical diagnoses and decision to
refer to an orthopaedic specialist who would decide
whether arthroscopy or other interventions were required
without the need for a follow-up appointment. The radi-
ologist's report could assist hospital specialists in prioritis-
ing outpatient appointments [17]. Finally the estimated
cost of accidents is £15 billion to the nation and approxi-
mately £1.2 billion per annum to the National Health
Service (NHS) [18]. Early access to MRI through referral
from primary care could contribute to the diagnosis and
management of these patients and potentially prevent the
onset of chronic problems and the psychological and eco-
nomic consequences of loss of physical fitness.
In contrast, some take the view that patients benefit more
by being referred quickly and directly by their GP to see an
orthopaedic specialist [8]. This would allow hospital spe-
cialists to use MRI much more selectively, limiting it to
those patients for whom a decision to operate has already
been made and thus reduce resources spent on MRI. They
argue that imaging may confuse the clinical picture if it
detects asymptomatic abnormalities, possibly leading to
unnecessary referrals and interventions [19]. Not all GPs
understand the implications of MRI findings as reported
by radiologists, and this could result in false reassurance
and delays in appropriate treatment [20].
A survey of the availability of MRI discovered that of 121
public sector departments with MRI who responded, 74
(61%) provided direct access to GPs for imaging of the
knee [21]. These findings imply wide variation in GPs'
access to MRI and provide further evidence of the uncer-
tainty where MRI should enter the diagnostic pathway. To
the extent that the distribution of scanners reflects past
demands of fundholding GPs, this variation may be more
politically driven than evidence based. Furthermore refer-
ral behaviour varies among GPs with direct access to MRI.
How such access affects the case mix of patients referred to
orthopaedic clinics is not known. Investment in primary
care is increasing, not least to prevent unnecessary referral
to secondary care; Primary Care Trusts will control over
80% of the NHS budget by 2007/8 [22]. In addition, the
UK Department of Health has announced plans to reduce
waiting times for diagnostic tests [23]. MRI provision is
expected to rise by around 12% a year [24]; nearly one
million MRI examinations are now performed in England
each year [25]. There is a real danger that GP access to MRI
will become standard policy without rigorous evaluation.
In contrast, timely access to a reliable diagnostic tool in
primary care has potential for better care and reduced
costs.
So our multi-centre, pragmatic randomised trial with two
parallel groups and concomitant economic evaluation
addresses the question whether patients presenting to GPs
with suspected internal derangement of the knee should
be referred for MRI or directly to an orthopaedic special-
ist? The principal objectives are to evaluate: whether the
use of MRI in primary or secondary care affects subse-
quent diagnosis and management; whether it improves
BMC Health Services Research 2006, 6:133 http://www.biomedcentral.com/1472-6963/6/133
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patient outcomes; and whether it reduces net costs to the
NHS, patients and society. In summary, our trial will
inform policy whether to allocate resources to permit MRI
for suspected internal derangement of the knee to enter
the diagnostic pathway in primary care through early
access for GPs, or to restrict it to secondary care at the
request of orthopaedic specialists.
Methods/Design
Trial design (Figure 1)
Experience from a wide range of trials in primary care sug-
gests that obtaining consent within a single consultation
is difficult. Therefore all potential trial participants were
given an information leaflet by their GP at the first consul-
tation. Patients who were then eligible, but uncertain
about whether to participate were encouraged to take at
least 24 hours to decide.
In each practice participating GPs or practice nurses ran-
domised eligible and consenting participants to one of the
two trial interventions: referral to the local radiology
department for an MRI examination underpinned by a
provisional orthopaedic referral; or referral as usual to the
local orthopaedic department for consultation with a spe-
cialist.
Interventions
Direct access to MRI (experimental intervention)
At each hospital, imaging was performed with standard
commercially available MR imagers using imaging proto-
cols at the discretion of the radiologist. 'Excess treatment
costs' were used to ensure that participants in the experi-
mental group could have early access to MRI within
twelve weeks of referral from their GP, who then used the
MRI findings to inform diagnosis and plan subsequent
management. Participants with normal MRI findings
received treatment including advice to return to normal
activities, undertake quadriceps exercises, and referral for
physiotherapy depending on their clinical history. GPs
were advised that when radiologists reported a serious
abnormality like a tumour on an MRI examination the
participant should be fast-tracked as normal.
To avoid contaminating our evaluation by differences in
waiting times between the two clinical policies, we asked
GPs to make a provisional referral to orthopaedics at the
same time as requesting MRI. This was to ensure that the
total waiting time from GP consultation to orthopaedic
appointment was similar for both trial arms. Thus the trial
will establish the more appropriate sequence of events
rather than try to assess the influence of variations in wait-
ing times.
There is evidence that educational interventions to sup-
port the dissemination of clinical guidelines can improve
GPs' knowledge of MRI use [26] and the routine attach-
ment of educational messages to radiologists' reports can
avoid unnecessary GP referral [27]. We therefore delivered
educational seminars to GPs about MRI, clinical diagnosis
and conservative management and attached the educa-
tional message shown in Figure 2 to the radiologists'
reports.
Referral to orthopaedic specialist in secondary care (the control 
intervention)
The potential delay between GP referral and a partici-
pant's outpatient appointment with an orthopaedic spe-
cialist varied across experimental sites from three to
eighteen months. We therefore used 'excess service sup-
port costs' when necessary to run extra clinics to reduce
the waiting time for an orthopaedic appointment from GP
referral to within nine months, and the delay between
orthopaedic consultation and arthroscopy to within nine
months. Reducing the waiting time from GP referral to
arthroscopy to eighteen months meant that following up
participants for two years would ensure the evaluation
covered most relevant events including arthroscopy.
Orthopaedic specialists decided whether to request MRI as
normal.
Inclusion and exclusion criteria
The target population for inclusion were people aged
between 18 and 55 years inclusive presenting in general
practice and for whom the GP was considering referral to
see an orthopaedic specialist for suspected internal
derangement of the knee (e.g. meniscal or ligamentous
injuries). Individual practices decided whether GP Regis-
trars should recruit and manage eligible patients. Consult-
ant radiologists could delegate reporting to Specialist
Registrars. Consultant orthopaedic surgeons could also
delegate to junior staff if appropriate.
Patients were excluded if:
• Their GP judged that they needed urgent orthopaedic
referral at the initial consultation (e.g. gross ligamentous
injury or sudden onset of effusion).
• They had suspected osteoarthritis, other non-traumatic
arthropathy, or isolated patello-femoral joint pain.
• They had chronic instability of the knee due to history
of major injury.
• They had a previous MRI examination within the same
episode of care.
• They had previous surgical intervention (excluding diag-
nostic arthroscopy) on the same knee.
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  Local co-ordinator presents to the GPs the trial procedures including:
eligibility criteria and informed consent
randomisation procedures
[the education package if GPs were unable to attend the 
   educational seminar]
Patient consults GP about knee problem
GP gives the patient an information leaflet.
GP assesses eligibility: 
a) If patient eligibility is confirmed then the GP explains the two
alternative pathways and the trial, and obtains patient’s consent;
pre-randomisation forms are completed, and randomisation
undertaken by telephone. 
b) If patient is not yet eligible, the GP manages him or her




GP questionnaire on receipt of imaging report or letter from orthopaedic specialist
Participant postal questionnaires after 6, 12 and 24 months
Educational seminar
  Local clinical collaborators and co-ordinator present information to GPs: 
diagnosis of patients with knee problems and treatments available
who would benefit from orthopaedic referral
how to interpret MRI findings
recruitment procedures
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• They had contraindications to the use of MRI, for exam-
ple pacemaker, intra-cranial aneurysm clips, or orbital
metallic foreign body.
Figures 3 and 4 summarise the guidance given to GPs to
differentiate between osteoarthritis and internal derange-
ment of the knee and how physiotherapy might be useful
before referral to an orthopaedic specialist.
Recruitment and allocation to interventions
The trial was based in sites across North Wales, North East
Scotland, and Yorkshire – areas covering urban, mixed
and rural settings and a broad socio-economic spectrum.
The total population of these geographical areas is around
two million people registered in over six hundred general
practices.
There is evidence that a multi-faceted strategy including
education, financial compensation and regular contact is
effective for recruiting GPs and patients [28]. Therefore
when practices were approached to participate in the trial
we offered GPs the opportunity to attend seminars to
learn about and discuss the trial and the choice of receiv-
ing payment or postgraduate education accreditation. The
seminars were held at places and times most convenient
for GPs. We also visited the practices of GPs unable to
attend the seminars and contacted others by telephone.
To cover expenses each participating practice received pay-
ments for committing themselves to the trial, recruiting
participants, and for completing all relevant documenta-
tion. During recruitment we updated participating prac-
tices through a newsletter, and maintained regular contact
by telephone and email. Posters were designed to alert
patients with knee problems about the study whilst wait-
ing for their appointment in general practice. We publi-
cised the trial through primary care newsletters, articles in
local newspapers, the trial website, and leaflets and post-
ers in local Accident & Emergency and Physiotherapy
Departments, pharmacies and sports centres. We also
asked hospitals to ensure that patient contact with MRI or
Orthopaedic Departments triggered referring GPs from
participating practices to consider recruiting a patient into
the trial if they had not already done so.
Ethical approval
The trial protocol was designed to comply with the Decla-
ration of Helsinki as adopted by the World Medical Asso-
ciation. Northern and Yorkshire Multi-Centre Research
Distinctive features of osteoarthritis rather than internal derangement of the kneeFigure 3
Distinctive features of osteoarthritis rather than internal derangement of the knee.
     More likely in older patients, although not exclusively 
     Pain: At rest        --  dull aching pain "like toothache" 
                       On activity  --  increases with walking 
On examination:       Deformity -- bowed, knock-kneed or fixed flexion        
                                              Crepitus on flexion or extension 
When there is suspicion that both conditions coexist, initial referral to an orthopaedic  
opinion is preferable to MRI so the patient would not be eligible for DAMASK. 
Educational reminderFigure 2
Educational reminder.
The decision to proceed to orthopaedic referral or to continue with conservative treatment in 
primary care should be based on both the MRI and clinical findings.  If you consider 
orthopaedic referral unnecessary please cancel the provisional appointment. 
BMC Health Services Research 2006, 6:133 http://www.biomedcentral.com/1472-6963/6/133
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Ethics Committee approved the protocol (reference
number MREC/1/3/59).
Obtaining consent
When patients consulted their GP with a knee problem,
the GP provided the patient with the information leaflet,
unless there was any obvious reason for exclusion. Prac-
tices that collected computerised data on consultations
were also asked to identify and send leaflets to patients
not previously identified at the time of their initial consul-
tation who might still be eligible. Patients who were eligi-
ble and agreed to consent were asked by their GP to
complete the baseline questionnaire.
Randomisation
When a participant completed the baseline questionnaire
a designated member of the practice phoned the remote
randomisation service at the University of York Trials Unit
for the random allocation. They then informed the partic-
ipant of their allocation and the GP made the appropriate
referrals. As the trial was pragmatic in design, so as to
reflect the consequences of routine GP access to MRI,
blinding of participants or professionals to treatment allo-
cation was not appropriate.
The randomisation service ensured immediate and unbi-
ased allocation of individual participants between the two
arms of the trial. The service recorded information to
identify all participants and their eligibility. There is evi-
dence of substantial inter-observer variability in radiolo-
gist reporting of MRI of the knee [29]; there is also
evidence that practice list size [30] and distance from gen-
eral practice to MRI centre [31] influence referral for MRI.
We therefore stratified the randomisation procedure by
experimental site, median distance from practice to hospi-
tal, and median number of partners in practices as a proxy
for practice list size. Within strata a block allocation
sequence was used; permuted random blocks of size 2 or
4 were randomly selected to generate the allocation
sequence.
When the trial began we recruited participants from prac-
tices in Hull and East Yorkshire, York and North York-
shire, Grampian and North Wales. Delays, for example in
the approval of NHS costs from North Wales, led us to
extend this invitation to practices to participate in
Lothian, Bradford, Rotherham, Sheffield and Tayside. We
modified the randomisation procedure for practices from
these sites to reduce administration and expedite recruit-
ment. The new procedure required the GP to establish eli-
gibility, obtain consent, make the orthopaedic referral,
and provide the participant with the baseline question-
naire and contact details form. The participant posted
completed forms to York where the Trial Secretary entered
Reasons to refer for physiotherapyFigure 4
Reasons to refer for physiotherapy.
Referral to physiotherapy should be helpful in the following situations:
In the acute phase early physiotherapy can relieve pain and effusion,  
            and assist diagnosis of underlying pathology.  
After acute knee injury, physiotherapy can assist pain relief, improve range 
           of movement, reduce effusion and improve strength, gait and overall function.  
Physiotherapy can be used to treat sub acute symptoms if early GP  
            management has failed.
Exclusions to physiotherapy:
Acute locked knee 
Gross ligamentous instability 
Severe effusion - requiring aspiration 
If physiotherapy is ineffective then refer patients to orthopaedic specialist. 
BMC Health Services Research 2006, 6:133 http://www.biomedcentral.com/1472-6963/6/133
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the data into the randomisation database, performed the
randomisation, and posted the results of the allocation to
the GP and the participant.
Stopping rules
Participants referred to orthopaedic departments were at
no greater risk than in normal clinical practice. MRI of the
knee has no serious side-effects providing the known con-
traindications are avoided, which is routine practice in
Radiology departments. A very small percentage of
patients find lying in the scanner space unpleasant [32].
As this is thus a pragmatic trial with very little risk to par-
ticipants, interim analyses were unnecessary.
Outcome measures
Participants completed a baseline questionnaire after giv-
ing informed consent but before randomisation. The
main outcome measures were self-assessed questionnaires
asking about participants' knee-related health, general
health, and demographic characteristics. Participants
received similar questionnaires by post six, twelve, and 24
months after random allocation. Existing evidence about
effective follow-up strategies enabled us to maximise the
effective sample size and reduce bias [33]. At six months
follow-up this included a reminder by post after two and
four weeks and by telephone after six weeks if necessary.
At twelve and 24 months this strategy was supplemented
with a two week pre-notification letter enclosing £5. This
money was given whether or not participants completed
questionnaires to cover expenses incurred in doing so. At
the final reminder six weeks after the 24 month follow up,
participants who had not returned the questionnaire
could choose to complete an abridged questionnaire by
telephone. This comprised the EQ-5D and five questions
from the knee-specific instrument that explained most of
the variation in participants' responses.
Health outcomes
In the absence of an appropriate patient-assessed health
instrument specific to the knee with satisfactory evidence
for reliability, validity, and responsiveness [34], we devel-
oped our own instrument. We complemented this instru-
ment with two generic measures useful for identifying
unexpected effects of interventions and for economic eval-
uation. The Short Form 36-item (SF-36) health survey is a
popular health profile that has been validated for use in
the NHS [35]. The EQ-5D generates a single index for val-
uing health states and is therefore suitable for cost-utility
analysis [36]. Both measures are responsive to changes in
the health of patients referred for MRI of the knee [37].
Health economic outcomes
Musculoskeletal problems and associated disabilities gen-
erate high costs – in health care (both within and outwith
the NHS), social security, and lost production [38]. A
broad economic evaluation is essential to inform com-
missioning and service decisions about the most efficient
policy for managing patients with continuing knee prob-
lems.
To estimate the incremental costs of each policy the eco-
nomic evaluation takes the perspective of both the NHS
and society. When we have completed the prospective col-
lection of data from participants, practices and hospitals
on NHS resources consumed we shall use these data to
estimate both the quantity of resources consumed and
complement this with the unit cost of each resource. Unit
cost data will be derived from reliable published sources
[39], the Department of Health Central cost estimates,
and from manufacturers.
Thus the data available for economic analysis are patient-
specific resource use and costs. Given the skewness inher-
ent in most cost data and the focus of analysis on mean
costs, we shall use bootstrapping to estimate confidence
intervals around the difference in mean costs [40,41]. The
base-case analysis will consider the costs and conse-
quences of direct access to MRI, reporting disaggregated
data on incremental costs and on the broad range of con-
sequences. The base-case analysis will consider both the
NHS perspective and a broader societal view where
patient costs and productivity issues will additionally be
incorporated. If one intervention clearly dominates the
other in both costs and consequences, then analysis will
be essentially complete. If there is no such dominance,
however, we shall use both cost-effectiveness (focusing on
cost per change in knee specific score) and cost-utility
analyses (focusing on cost per quality-adjusted life year
(QALY) gained), as estimated from the EQ-5D instru-
ment. Results will be presented using cost-effectiveness
acceptability curves to reflect sampling variation and
uncertainty in the threshold value of a QALY. We shall
also use simple and probabilistic sensitivity analyses to
explore whether these results are robust to plausible vari-
ations in key assumptions (e.g. average appointment
times) and variations in analytical methods, and to con-
sider the generalisability of the results.
Referral process
To measure 'diagnostic and therapeutic impact' of direct
access to MRI, we asked GPs to complete a pre-randomi-
sation questionnaire that recorded their diagnosis, man-
agement plans and confidence therein [42]. We asked
them to complete a similar questionnaire on receipt of the
imaging report or orthopaedic specialist letter. We also
record the patient waiting times from randomisation to
MRI, orthopaedic consultation, and arthroscopy. Adher-
ence to the referral process is one of the outcomes of inter-
est rather than a factor that may jeopardise interpretation
of the findings.
BMC Health Services Research 2006, 6:133 http://www.biomedcentral.com/1472-6963/6/133
Page 8 of 9
(page number not for citation purposes)
Sample size
A similar group of patients followed up six months after
referral for MRI of the knee had a mean of 64 and standard
deviation (SD) of 25 on the physical functioning sub-
scale of the SF-36 [37]. Hence a trial that followed up 434
participants (217 direct access and 217 controls) would
have 80% power using a 5% significance level to identify
a standardised difference of 0.27, equivalent to 6.75
points on the SF-36 physical sub-scale or an analogous
difference on the proposed knee-specific instrument. We
judge that a standardised difference of 0.27 in either of
these measures should be clinically important. As we esti-
mated that we could achieve 85% response rates to postal
questionnaires, we aimed to recruit 500 participants in all.
Statistical analyses
The primary outcome measures are the physical function-
ing sub-scale of the SF-36 and the knee-specific instru-
ment. The trial is pragmatic in design and therefore the
primary analysis will be 'by intention to treat' in that all
participants properly randomised will be included in the
analysis even if they do not receive the intervention they
were allocated to receive. A secondary analysis will be lim-
ited to participants who received the treatment to which
they were randomised.
Data were collected at four time points: baseline, six,
twelve, and 24 months. We shall use PROC, the mixed
model procedure in the Statistical Analysis System (SAS),
to analyse the data from all four time points within a sin-
gle model and to adjust for experimental site. This model
is robust to data missing at random and can also take the
covariance structure of the data into account [43]. We
shall check that the data fulfil the assumptions of the
mixed model. If the data are not missing at random we
shall seek an alternative analytical method providing a
better fit. We shall treat missing items within individual
outcome measures according to the instructions for that
measure. For each outcome measure we shall calculate the
number of non-responders and compare the proportion
and type of non-response in each group at each time
point. We shall also check that the model is a good fit and
transform the data if necessary to improve fit.
The secondary outcome measures are the other seven sub-
scales of the SF-36, the EQ-5D itself, the number of days
patients take off work for their knee problems, and the
number of days they are prevented from doing normal
activities by their knee problems. The EQ-5D and the
other seven subscales of the SF-36 will be analysed the
same way as the primary outcome measures. As the
number of days off work or normal activities is likely to
follow a skewed distribution we shall transform the data
and present the median and inter-quartile ranges for these
times.
Secondary analysis of the primary outcome measures will
be performed to adjust for the variation in waiting times
between GP referral and access to MRI or orthopaedic spe-
cialist. Further analyses will test whether variables such as
age and sex affect patient outcome, and to compare find-
ings between different types of knee injuries (e.g. meniscal
or ligamentous). As this analysis will not have the same
power as the trial as a whole it will generate hypothesis
rather than test them definitively.
Discussion
We have designed the DAMASK trial to evaluate the role
of MRI within primary care and contribute to improved
communication and evidence-based partnerships
between primary and secondary care professionals.
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